UnitedHealthcare, a leading healthcare services company, presented its financial outlook and strategic initiatives at the Wells Fargo 21st Annual Healthcare Conference. The company reported a stock price of $400.84, with a market capitalization of $359.79 billion, reflecting a 41% surge over the past six months. Trailing twelve-month revenue reached $450.53 billion, with a price-to-earnings ratio of 25.96 and a consistent dividend yield of 2.32%.
The company's Medicare Advantage segment is tracking toward the upper half of its 2% to 4% target range for 2026. Medicaid margins are guided within a negative 1.1% to negative 1.7% range, with blended rate increases materializing at 6% to 7%. Optum Insight is expected to operate within an 18% to 22% margin range, finishing 2026 near the top end. Public Exchange margins are in the low single digits, with a long-term target of a sustainable 2% margin level. Optum Health is targeting 6% to 8% margins by 2028.
UnitedHealthcare's turnaround efforts are focused on cost management and technology adoption. Indirect Delivery Route (IDR) costs are adding about 100 basis points of cost in commercial business, compared to a 50 basis point base in 2025. The company expects its debt-to-capitalization ratio to improve from about 45% last year to about 40% by the fourth quarter of 2026. The 2026 buyback plan has been raised to at least $5 billion, up from an initial $2.5 billion. Patient-facing hours rose more than 12% in the first half of 2026.
Krista Nelson, CEO of Optum Health, emphasized the importance of clinical management and operating execution in driving the company's outperformance. Ben Eklo, CFO of Optum, highlighted the company's multi-year journey to modernize its cost structure through technology and AI. Wayne DeVeydt, CFO of UnitedHealthcare, expressed optimism about the company's turnaround, noting that the velocity of progress is expected to accelerate in 2027 and 2028.
UnitedHealthcare's strategic initiatives include automation of call handling, claims, approvals, clinical documentation, ambient listening for physicians, payment integrity, risk and quality, revenue cycle management, and corporate functions. The company is targeting to have finance fully automated by the end of 2027. Regarding a news report about selling value-based care assets in Florida to private equity, Krista Nelson clarified that UnitedHealthcare is not exiting Florida but is making strategic investments with a partner, retaining ownership and incentive alignment.
